Wave Life Sciences Ltd. (WVE)
NASDAQ: WVE · Real-Time Price · USD
6.85
+0.03 (0.44%)
Sep 17, 2025, 2:56 PM EDT - Market open
Wave Life Sciences Stock Forecast
Stock Price Forecast
The 17 analysts that cover Wave Life Sciences stock have a consensus rating of "Strong Buy" and an average price target of $19.94, which forecasts a 191.09% increase in the stock price over the next year. The lowest target is $10 and the highest is $36.
Price Target: $19.94 (+191.09%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 6 | 7 | 8 |
| Buy | 5 | 5 | 7 | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 13 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +162.77% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +221.17% | Sep 3, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +177.37% | Aug 4, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $24 → $21 | Buy | Maintains | $24 → $21 | +206.57% | Jul 31, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $24 | Buy | Initiates | $24 | +250.36% | Jul 28, 2025 |
Financial Forecast
Revenue This Year
49.42M
from 108.30M
Decreased by -54.37%
Revenue Next Year
54.37M
from 49.42M
Increased by 10.02%
EPS This Year
-1.15
from -0.70
EPS Next Year
-1.20
from -1.15
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 89.3M | 126.0M | |||
| Avg | 49.4M | 54.4M | |||
| Low | 17.5M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -17.6% | 155.0% | |||
| Avg | -54.4% | 10.0% | |||
| Low | -83.8% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.97 | -0.84 | |||
| Avg | -1.15 | -1.20 | |||
| Low | -1.39 | -1.73 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.